---
figid: PMC4250230__nihms640682f4
figtitle: 'Targeting RAF kinases for cancer therapy: BRAF mutated melanoma and beyond'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4250230
filename: nihms640682f4.jpg
figlink: /pmc/articles/PMC4250230/figure/F4/
number: F4
caption: 'Multiple mechanisms of acquired resistance (highlighted in blue) to BRAF-V600E
  inhibitors lead to reactivation of the MEK-ERK pathway (highlighted in red) in the
  presence of a RAF inhibitor. The mechanisms of resistance include: activating mutations
  (*) of NRAS, overexpression (↑) of CRAF, overexpression of BRAF-V600E itself, alternative
  splicing of BRAF that renders the protein immune to inhibitors (p61), overexpression
  of COT, mutational activation of MEK1 and MEK2, ligand dependent RAS signaling through
  PDGFRβ or IGF-1R, or stromal cell secretion of HGF to activate through c-MET signaling.'
papertitle: 'Targeting RAF kinases for cancer therapy: BRAF mutated melanoma and beyond.'
reftext: Matthew Holderfield, et al. Nat Rev Cancer. ;14(7):455-467.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9571052
figid_alias: PMC4250230__F4
figtype: Figure
redirect_from: /figures/PMC4250230__F4
ndex: 7aff47c8-dea2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4250230__nihms640682f4.html
  '@type': Dataset
  description: 'Multiple mechanisms of acquired resistance (highlighted in blue) to
    BRAF-V600E inhibitors lead to reactivation of the MEK-ERK pathway (highlighted
    in red) in the presence of a RAF inhibitor. The mechanisms of resistance include:
    activating mutations (*) of NRAS, overexpression (↑) of CRAF, overexpression of
    BRAF-V600E itself, alternative splicing of BRAF that renders the protein immune
    to inhibitors (p61), overexpression of COT, mutational activation of MEK1 and
    MEK2, ligand dependent RAS signaling through PDGFRβ or IGF-1R, or stromal cell
    secretion of HGF to activate through c-MET signaling.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - IL6
  - SOS1
  - IGF1R
  - PDGFRB
  - NRAS
  - KRAS
  - HRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP3K8
  - CROT
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
